For instance, methylation of genes such as SHOX2 and RASSF1A in plasma has been associated with lung cancer in its early stages, demonstrating the potential of blood-based assays for non-invasive screening [12,13]. The gene discussed is SHOX2; the disease is lung carcinoma.